Watson Pharmaceuticals WPI
-
New drugs help Actavis beat profit estimates
May 2 (Reuters) - Generic drugmaker Actavis Inc, formerly known as Watson Pharmaceuticals , reported an adjusted quarterly profit that beat market estimates, helped by new products, and the company raised its earnings forecast for the full year.
-
Stockton is Bankrupt: Now What?
… Report: Merck Analyst Report: Mylan Technologies MYL Analyst Report: Teva Pharmaceuticals Analyst Report: Watson Pharmaceuticals WPI Rethinking Title Insurer Moat, Risk Ratings Analyst Jim Ryan reduced the moat rating and increased the risk …
-
Actavis Previews Financial Results and Highlights Plan for Future Growth
Now trading under its official new name, Actavis ACT (formerly Watson Pharmaceuticals ) highlighted its long-term growth strategy and presented expectations for the current quarter and upcoming 2013 results at its …
-
Actavis, formerly Watson, sees 2013 profit growth
Jan 25 (Reuters) - Actavis Inc, the generic drugmaker previously known as Watson Pharmaceuticals , said on Friday that it expected earnings to rise at least 30 percent in 2013 as it expands globally, but its outlook still came in short of analysts' expectations.
-
Watson Pharmaceuticals ( WPI ) announces plans to restructure operations at its Corona, California facility. As such, manufacturing and related support functions at the site will be reduced and ...
Watson Pharmaceuticals ( WPI ) announces plans to restructure operations at its Corona, California facility. As such, manufacturing and related support functions …
-
Watson seeks approval of generic version of cancer drug Velcade
Dec 28 (Reuters) - Watson Pharmaceuticals Inc said on Friday it has applied for U.S. approval to market a generic version of Velcade, a treatment for multiple myeloma made by Takeda Pharmaceutical Co.
-
Columbia Laboratories Inc.: Recent Events Lead To An Opportune Entry Point
… Columbia Laboratories Inc.( CBRX ) confirmed that the U.S. Food and Drug Administration (FDA) had denied Watson Pharmaceuticals , Inc .'s ( WPI ) Formal Dispute Resolution Request (FDRR) related to its New Drug Application (NDA 22-139 …
-
The Generics Empire Of Watson Pharma Soon To Be Named Actavis
By Peter Geschek : In 2013 Watson Pharmaceuticals ( WPI ) is changing its name to Actavis because the brand is more recognizable globally and to avoid confusion with other businesses …
-
Watson Pharmaceuticals Management Discusses Q3 2012 Results - Earnings Call Transcript
Watson Pharmaceuticals ( WPI ) Q3 2012 Earnings Call November 01, 2012 8:30 am ET Executives Lisa M. Defrancesco - Former Vice President of Global Investor …
-
Watson Pharmaceutical: Superb Quality Of Earnings Is Catalyst To Push Shares Higher
By Jason Merriam : Watson Pharmaceuticals ( WPI ) is a leading integrated global pharmaceutical company engaged in the development, manufacturing, marketing, sale, and distribution …